流通市值:12.18亿 | 总市值:27.33亿 | ||
流通股本:2614.00万 | 总股本:5864.00万 |
报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
公司类型 | 通用 | 通用 | 通用 | 通用 |
流动资产: | ||||
货币资金 | 388,787,616.84 | 381,907,767.59 | 281,349,605.49 | 238,308,880.99 |
结算备付金 | 0 | 0 | - | - |
拆出资金 | 0 | 0 | - | - |
衍生金融资产 | 0 | 0 | - | - |
应收票据及应收账款 | 363,522,180.98 | 396,871,929.1 | 377,677,327.97 | 331,488,123.03 |
其中:应收票据 | 81,759,899.88 | 83,103,705.12 | 74,037,417.51 | 60,052,269.88 |
应收账款 | 281,762,281.1 | 313,768,223.98 | 303,639,910.46 | 271,435,853.15 |
应收款项融资 | 44,956,402.49 | 29,844,921.41 | 29,782,351.44 | 35,868,103.73 |
预付款项 | 4,169,633.84 | 4,318,141.23 | 8,079,899.05 | 7,552,468.24 |
应收保费 | 0 | 0 | - | - |
应收分保账款 | 0 | 0 | - | - |
应收分保合同准备金 | 0 | 0 | - | - |
其他应收款合计 | 5,597,741.95 | 2,814,562.35 | 1,756,749.95 | 1,614,941.3 |
其中:应收利息 | 0 | 0 | - | - |
应收股利 | 0 | 0 | - | - |
买入返售金融资产 | 0 | 0 | - | - |
存货 | 69,960,605.93 | 72,209,916.36 | 83,717,158.69 | 66,794,592.61 |
合同资产 | 0 | 0 | - | - |
一年内到期的非流动资产 | 0 | 0 | - | - |
其他流动资产 | 5,397,195.16 | 6,585,111.98 | 6,457,636.8 | 6,367,000.11 |
流动资产平衡项目 | 0 | 0 | 0 | 0 |
流动资产合计 | 1,212,639,035.92 | 1,202,895,923.15 | 1,160,407,574.48 | 1,105,483,725.09 |
非流动资产: | ||||
发放委托贷款及垫款 | 0 | 0 | - | - |
债权投资 | 0 | 0 | - | - |
其他债权投资 | 0 | 0 | - | - |
长期应收款 | 0 | 0 | - | - |
长期股权投资 | 0 | 0 | - | - |
其他权益工具投资 | 0 | 0 | - | - |
其他非流动金融资产 | 0 | 0 | - | - |
投资性房地产 | 16,229,918.65 | 16,358,839.93 | 16,487,761.21 | 16,616,682.49 |
固定资产 | 47,104,038.34 | 47,280,573.3 | 48,054,430.79 | 49,173,455.04 |
在建工程 | 474,398.87 | 143,564.36 | - | - |
生产性生物资产 | 0 | 0 | - | - |
油气资产 | 0 | 0 | - | - |
使用权资产 | 841,608.34 | 992,557.96 | 1,006,720.4 | 1,087,254.02 |
无形资产 | 5,998,795.48 | 6,102,702.34 | 5,925,051.81 | 6,025,703.16 |
开发支出 | 0 | 0 | - | - |
商誉 | 264,082.8 | 264,082.8 | 264,082.8 | 264,082.8 |
长期待摊费用 | 2,022,251.12 | 2,220,854.17 | 1,655,586.97 | 1,923,084.59 |
递延所得税资产 | 5,268,936.39 | 4,855,080.67 | 5,250,122.54 | 4,954,926.02 |
其他非流动资产 | 2,900,000 | 3,176,000 | - | - |
非流动资产平衡项目 | 0 | 0 | 0 | 0 |
非流动资产合计 | 81,104,029.99 | 81,394,255.53 | 78,643,756.52 | 80,045,188.12 |
资产平衡项目 | 0 | 0 | 0 | 0 |
资产总计 | 1,293,743,065.91 | 1,284,290,178.68 | 1,239,051,331 | 1,185,528,913.21 |
流动负债: | ||||
短期借款 | 0 | 0 | - | - |
向中央银行借款 | 0 | 0 | - | - |
吸收存款及同业存放 | 0 | 0 | - | - |
拆入资金 | 0 | 0 | - | - |
交易性金融负债 | 0 | 0 | - | - |
衍生金融负债 | 0 | 0 | - | - |
应付票据及应付账款 | 69,058,708.29 | 70,403,499.56 | 57,184,879.2 | 39,193,368.76 |
其中:应付票据 | 26,348,968.58 | 32,348,968.58 | 6,000,000 | 6,932,260 |
应付账款 | 42,709,739.71 | 38,054,530.98 | 51,184,879.2 | 32,261,108.76 |
预收款项 | 0 | 0 | - | - |
合同负债 | 2,986,755.64 | 1,719,014.25 | 3,283,145.37 | 5,978,171.95 |
卖出回购金融资产款 | 0 | 0 | - | - |
应付手续费及佣金 | 0 | 0 | - | - |
应付职工薪酬 | 8,664,159.57 | 13,425,023.26 | 10,327,782.53 | 11,048,308.56 |
应交税费 | 8,862,592.48 | 7,489,741.79 | 6,680,629.21 | 5,938,193.48 |
其他应付款合计 | 1,957,035.63 | 2,046,914.16 | 1,841,765.33 | 1,510,479.64 |
其中:应付利息 | 0 | 0 | - | - |
应付股利 | 0 | 0 | - | - |
应付分保账款 | 0 | 0 | - | - |
保险合同准备金 | 0 | 0 | - | - |
代理买卖证券款 | 0 | 0 | - | - |
代理承销证券款 | 0 | 0 | - | - |
一年内到期的非流动负债 | 468,184.47 | 501,959.44 | 584,876.68 | 602,197.88 |
其他流动负债 | 42,887,572.34 | 50,226,782.53 | 47,181,637.78 | 34,339,015.52 |
流动负债平衡项目 | 0 | 0 | 0 | 0 |
流动负债合计 | 134,885,008.42 | 145,812,934.99 | 127,084,716.1 | 98,609,735.79 |
非流动负债: | ||||
长期借款 | 0 | 0 | - | - |
应付债券 | 0 | 0 | - | - |
优先股 | 0 | 0 | - | - |
永续债 | 0 | 0 | - | - |
租赁负债 | 369,217.3 | 485,774.97 | 219,168.8 | 350,813.96 |
长期应付款 | 0 | 0 | - | - |
长期应付职工薪酬 | 0 | 0 | - | - |
预计负债 | 0 | 0 | - | - |
递延收益 | 2,083,739.2 | 2,311,449.55 | 1,751,659.89 | 1,891,870.24 |
递延所得税负债 | 193,580.19 | 225,626.04 | 238,026.76 | 223,442.27 |
其他非流动负债 | 0 | 0 | - | - |
非流动负债平衡项目 | 0 | 0 | 0 | 0 |
非流动负债合计 | 2,646,536.69 | 3,022,850.56 | 2,208,855.45 | 2,466,126.47 |
负债平衡项目 | 0 | 0 | 0 | 0 |
负债合计 | 137,531,545.11 | 148,835,785.55 | 129,293,571.55 | 101,075,862.26 |
所有者权益(或股东权益): | ||||
实收资本(或股本) | 58,640,000 | 58,640,000 | 58,640,000 | 58,640,000 |
其他权益工具 | 0 | 0 | - | - |
优先股 | 0 | 0 | - | - |
永续债 | 0 | 0 | - | - |
资本公积 | 672,948,917.25 | 672,948,917.25 | 672,948,917.25 | 672,948,917.25 |
减:库存股 | 0 | 0 | - | - |
其他综合收益 | 0 | 812,345 | - | - |
专项储备 | 4,887,226.68 | 4,928,069.11 | 4,850,286.27 | 4,891,270.68 |
盈余公积 | 29,320,000 | 29,320,000 | 29,320,000 | 29,320,000 |
一般风险准备 | 0 | 0 | - | - |
未分配利润 | 390,415,376.87 | 368,805,061.77 | 343,998,555.93 | 318,652,863.02 |
归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
归属于母公司股东权益合计 | 1,156,211,520.8 | 1,135,454,393.13 | 1,109,757,759.45 | 1,084,453,050.95 |
少数股东权益 | 0 | 0 | - | - |
股东权益平衡项目 | 0 | 0 | 0 | 0 |
股东权益合计 | 1,156,211,520.8 | 1,135,454,393.13 | 1,109,757,759.45 | 1,084,453,050.95 |
负债和股东权益合计 | 1,293,743,065.91 | 1,284,290,178.68 | 1,239,051,331 | 1,185,528,913.21 |
公告日期 | 2024-04-23 | 2024-04-23 | 2023-10-27 | 2023-08-29 |
审计意见(境内) | 标准无保留意见 |